The Research and Development Scientists at RayzeBio focus on designing and developing innovative radiopharmaceuticals tailored for targeted cancer therapy. This multidisciplinary team collaborates on drug formulation, radiochemistry, and data analytics to optimize therapeutic efficacy and safety, advancing the pipeline of treatments aimed at improving survival rates for patients with solid tumors.
View all